(technologies available for licensing)
Note: Links to Patents may require a browser newer than Internet Explorer 9, such as Chrome, Safari, Firefox, Edge, or Internet Explorer 11| TECH ID | TITLE | LEAD INVENTOR | CONTACT |
|---|---|---|---|
|
07-43 |
Biomarkers for Early Pancreatic Cancer Detection and Treatment |
Anthony Yeung |
|
|
256-JT |
Novel Diagnostic and Prognostic Marker for Malignant Mesothelioma |
Joseph Testa |
|
|
305-MC |
Estrogen Metabolite Levels and CYP1B1 Polymorphisms in Lung Cancer Diagnosis, Prognosis, and Risk Assessment |
Margie Clapper |
|
|
312-GE |
Novel Diagnostic Method for Predisposition to Colorectal Cancer |
Greg Enders |
|
|
394-EG |
Novel Biomarkers for Prognosis and Diagnosis of Prostate Cancer Published Application No.WO2017049023A1; Summary Other Patent Applications Pending |
Erica Golemis |
|
|
396-EC |
Novel Biomarker For Risk Assessment And Treatment Evaluation For Cancers With Fibrosis |
Edna Cukierman |
|
|
426-SA |
Methods For Diagnosis And Treatment Of Patients Having Solid Tumors |
Sanjeevani Arora |
|
|
431-WE |
High EGFR Somatic Mutation Frequency Targeting the TK Domain in Colorectal Cancer Patients with Microsatellite Instability (MSI) |
Wafik El-Deiry |
|
|
443-JFB |
Novel Cancer Prognostic based on MHC-I Genotype and Presentability |
Joan Font-Burgada |
|
|
461-PA |
Urinary DNA Detection for Monitoring of Urothelial Cancer |
Philip Abbosh |
|
|
516-ZY |
Applications of exosomes in the diagnosis of brain tumors |
Zeng-Jie Yang |
|
|
522-MC |
Estrogen Metabolite Levels and EGFR Mutations in Lung Cancer Risk Stratification and Treatment |
Margie Clapper |
|
|
534-JR |
The usage of r-HCG and the genomic signature of the breast induced by r-HCG in BRCA 1/2 carriers |
Jose Russo |
|
|
546-JT |
Malignant Mesothelioma Susceptibility as a Result of Germline Gene Alteration: novel prognostic and diagnostic marker for mesothelioma. Patent pending; Summary |
Joseph Testa |